Japan’s health ministry on Tuesday approved the first domestically developed COVID-19 vaccine that works against the currently circulating XBB.1.5 sublineage of the omicron variant.
About the Author
Japan’s health ministry on Tuesday approved the first domestically developed COVID-19 vaccine that works against the currently circulating XBB.1.5 sublineage of the omicron variant.
